Stage FocusSeed, Series A
GeographyUS, Global
TypeCVC
Last Activity2024
Industry Focus
Industries
MedtechBiotechHardwareIoT & EdgeCybersecurity
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
Dexcom Ventures launched in February 2021 as the CVC arm of Dexcom, the $10B+ market cap leader in continuous glucose monitoring (CGM). Led by Jason Halac (MD) with over 20 years of combined team experience, the fund has made 9 targeted investments in biosensing technology and data-driven healthcare adjacent to Dexcom's CGM core. The portfolio is highly focused: Beta Bionics (iLet Bionic Pancreas)...
Notable Investments
B
Beta BionicsS
SignosN
NutromicsE
EpitelB
BiointelliSenseM
MedcryptSimilar Funds
T
Triventures
Herzliya, Israel
DeepTech NativeMedtechCybersecurityHardwareSeedSeries A
AV
Ascension Ventures
St. Louis, Missouri, United States
Industrial / CVCMedtechAICybersecurityPre-SeedSeed
AV
AV8 Ventures
Palo Alto, United States
Industrial / CVCMedtechCybersecuritySeedSeries A
BV
Batterson Venture Capital
Chicago, United States
Pure DeepTechMedtechBiotechSpacePre-SeedSeed
B
BrightEdge
Kennesaw, United States
Industrial / CVCMedtechBiotechSeedSeries A
Catapult Ventures
Leicester, United Kingdom
DeepTech NativeMedtechRoboticsIoT & EdgeSeedSeries A